Home
>
National Drug Code (NDC)
>
Clarinex
Clarinex - 21695-815-10 - (Desloratadine)
Drug Information of Clarinex
| Product NDC: | 21695-815 |
| Proprietary Name: | Clarinex |
| Non Proprietary Name: | Desloratadine |
| Active Ingredient(s): | 5 mg/1 & nbsp; Desloratadine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clarinex
| Product NDC: | 21695-815 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021297 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020208 |
Package Information of Clarinex
| Package NDC: | 21695-815-10 |
| Package Description: | 10 TABLET, FILM COATED in 1 BOTTLE (21695-815-10) |
NDC Information of Clarinex
| NDC Code | 21695-815-10 |
| Proprietary Name | Clarinex |
| Package Description | 10 TABLET, FILM COATED in 1 BOTTLE (21695-815-10) |
| Product NDC | 21695-815 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Desloratadine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20020208 |
| Marketing Category Name | NDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | DESLORATADINE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
